91168-75-1Relevant academic research and scientific papers
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
-
, (2019/09/30)
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
Diversity-oriented synthesis of 1-hydroxy-2,4-benzodioates by regioselective [3+3] cyclocondensations of 1,3-bis(silyloxy)-1,3-butadienes with 3-alkoxy- and 3-silyloxy-2-alkoxycarbonyl-2-en-1-ones
Shkoor, Mohanad,Riahi, Abdolmajid,Fatunsin, Olumide,Hussain, Ibrar,Yawer, Mirza A.,Lubbe, Mathias,Reim, Stefanie,Reinke, Helmut,Fischer, Christine,Langer, Peter
scheme or table, p. 2182 - 2186 (2009/09/05)
1-Hydroxy-3,5-dimethyl-2,4-benzodioates (4-hydroxyisophthalates) were prepared by [3+3] cyclocondensation of 1,3-bis(silyloxy)-1,3-butadienes with 3-ethoxycarbonyl-4-trimethylsilyloxy-3-penten-2-one which is synthesized from (symmetrical) ethyl 2-acetylacetoacetate. The [3+3] cyclization of 1,3-bis(silyloxy)-1,3-butadienes with 3-alkoxy-2-alkoxycarbonyl-2-en-1-ones, readily available by reaction of β-ketoesters with trialkyl orthoformiates, provide a convenient and regioselective approach to a great variety of 3-substituted 1-hydroxy-2,4-benzodioates that are not readily available by other methods.
New Pyridine Analogues IX 519
-
Page/Page column 36, (2008/12/06)
The present invention relates to certain new pyridin analogues of Formula (I) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.
2-piperazinopyrimidine derivatives
-
, (2008/06/13)
The present invention relates to novel 2-piperazinopyrimidine derivatives represented by the following general formula [I] which are useful as, for example, an active ingredient of herbicides STR1 wherein R1 is a hydrogen atom or an aralkyl group and Y is one of the groups represented by the following general formulas [II] to [VII] STR2 (wherein a and b are positions to be bound to positions 4 and 5 of the pyrimidine ring of the formula [I], respectively; l1 and l2 each are an integer of 2 to 4; l3 is 2 or 0; l4 is 0 or 1, provided that l4 is 0 when l3 is 2 and l4 is 1 when l3 is 0; l5 is 2 or 3; l6 is 1 or 2; l7 is 2 or 3; R2 is a hydroxyl group or a toluenesulfonyloxy group; and R3, R4, R5, R6 and R7 each are a hydrogen atom or a lower alkyl group).
